Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker IONS
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Shannon L. Devers Officer | IONS Ionis Pharmaceuticals, Inc. | 1,357 | $59.7K | — | Oct 16, 2026 | Form 4 ↗ 3 days later · 1,357 shares | Form 144 ↗ |
| Jul 7, 2026 | Allene M. Diaz Director | IONS Ionis Pharmaceuticals, Inc. | 10,111 | $863.6K | 10b5-1 | Jul 7, 2026 | Form 4 ↗ 2 days later · 10,111 shares | Form 144 ↗ |
| Jul 7, 2026 | Holly B. Kordasiewicz Officer | IONS Ionis Pharmaceuticals, Inc. | 1,287 | $108.5K | 10b5-1 | Jul 7, 2026 | Form 4 ↗ 2 days later · 362 shares | Form 144 ↗ |
| Jul 7, 2026 | C. Frank Bennett Officer | IONS Ionis Pharmaceuticals, Inc. | 67,386 | $5.7M | 10b5-1 | Jul 7, 2026 | Form 4 ↗ 2 days later · 20,536 shares | Form 144 ↗ |
| Jul 1, 2026 | Joseph Klein III Director | IONS Ionis Pharmaceuticals, Inc. | 11,518 | $910.4K | 10b5-1 | Jul 1, 2026 | Form 4 ↗ 5 days later · 11,518 shares | Form 144 ↗ |
| Jun 26, 2026 | Baroldi Mariana Member of immediate family of any of th… | IONS Ionis Pharmaceuticals, Inc. | 5,635 | $451.7K | 10b5-1 | Jun 26, 2026 | — | Form 144 ↗ |
| Jun 26, 2026 | Patrick R. O'Neil Officer | IONS Ionis Pharmaceuticals, Inc. | 3,069 | $245.5K | 10b5-1 | Jun 26, 2026 | Form 4 ↗ 4 days later · 3,069 shares | Form 144 ↗ |
| Jun 26, 2026 | Eugene Schneider Officer | IONS Ionis Pharmaceuticals, Inc. | 47,884 | $3.9M | 10b5-1 | Jun 26, 2026 | Form 4 ↗ 4 days later · 26,000 shares | Form 144 ↗ |
| Jun 25, 2026 | Eric Swayze Officer | IONS Ionis Pharmaceuticals, Inc. | 10,602 | $839.3K | 10b5-1 | Jun 25, 2026 | Form 4 ↗ 1 day later · 10,602 shares | Form 144 ↗ |
| Jun 15, 2026 | Spencer R. Berthelsen Director | IONS Ionis Pharmaceuticals, Inc. | 8,000 | $587.9K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 1 day later · 8,000 shares | Form 144 ↗ |
| Jun 12, 2026 | Holly B. Kordasiewicz Officer | IONS Ionis Pharmaceuticals, Inc. | 60,846 | $4.5M | 10b5-1 | Jun 12, 2026 | Form 4 ↗ 4 days later · 60,846 shares | Form 144 ↗ |
| Jun 1, 2026 | Spencer R. Berthelsen Director | IONS Ionis Pharmaceuticals, Inc. | 8,000 | $605.4K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 2 days later · 8,000 shares | Form 144 ↗ |
| May 13, 2026 | Brett P. Monia Officer | IONS Ionis Pharmaceuticals, Inc. | 100,000 | $7.8M | 10b5-1 | May 13, 2026 | Form 4 ↗ 2 days later · 4,536 shares | Form 144 ↗ |
| May 4, 2026 | Joseph Loscalzo Director | IONS Ionis Pharmaceuticals, Inc. | 54,321 | $4.3M | 10b5-1 | May 4, 2026 | Form 4 ↗ 2 days later · 77,289 shares | Form 144 ↗ |
| Apr 28, 2026 | Joseph Baroldi Officer | IONS Ionis Pharmaceuticals, Inc. | 1,626 | $116.7K | 10b5-1 | Apr 28, 2026 | Form 4 ↗ 2 days later · 1,626 shares | Form 144 ↗ |
| Apr 16, 2026 | Kyle Jenne Officer | IONS Ionis Pharmaceuticals, Inc. | 4,902 | $369.6K | — | Apr 16, 2026 | Form 4 ↗ 1 day later · 4,902 shares | Form 144 ↗ |
| Apr 16, 2026 | Brian Birchler Officer | IONS Ionis Pharmaceuticals, Inc. | 973 | $73.4K | — | Apr 16, 2026 | Form 4 ↗ 1 day later · 973 shares | Form 144 ↗ |
| Apr 16, 2026 | Joseph Baroldi Officer | IONS Ionis Pharmaceuticals, Inc. | 5,619 | $423.7K | — | Apr 16, 2026 | Form 4 ↗ 1 day later · 5,619 shares | Form 144 ↗ |
| Mar 31, 2026 | Allene M. Diaz Director | IONS Ionis Pharmaceuticals, Inc. | 68,800 | $5.5M | 10b5-1 | Mar 3, 2026 | — | Form 144 ↗ |
| Mar 24, 2026 amended | Eugene Schneider Officer | IONS Ionis Pharmaceuticals, Inc. | 5,812 | $412.5K | 10b5-1 | Mar 19, 2026 | — | Form 144/A ↗ |
| Mar 19, 2026 | Eugene Schneider Officer | IONS Ionis Pharmaceuticals, Inc. | 5,812 | $412.5K | 10b5-1 | Mar 19, 2026 | Form 4 ↗ 4 days later · 5,812 shares | Form 144 ↗ |
| Mar 16, 2026 | Elizabeth L. Hougen Officer | IONS Ionis Pharmaceuticals, Inc. | 225,200 | $16.3M | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 2 days later · 225,220 shares | Form 144 ↗ |
| Mar 10, 2026 | Kyle Jenne Director | IONS Ionis Pharmaceuticals, Inc. | 58,253 | $4.4M | 10b5-1 | Mar 10, 2026 | Form 4 ↗ 1 day later · 37,277 shares | Form 144 ↗ |
| Mar 9, 2026 | Patrick R. O'Neil Officer | IONS Ionis Pharmaceuticals, Inc. | 13,217 | $994.6K | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 2 days later · 10,148 shares | Form 144 ↗ |
| Mar 3, 2026 amended | C. Frank Bennett Officer | IONS Ionis Pharmaceuticals, Inc. | 85,089 | $7.1M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 85,089 shares | Form 144/A ↗ |
| Mar 3, 2026 | Joseph Loscalzo Director | IONS Ionis Pharmaceuticals, Inc. | 24,000 | $1.9M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 1,032 shares | Form 144 ↗ |
| Mar 3, 2026 | Baroldi Mariana Officer | IONS Ionis Pharmaceuticals, Inc. | 8,198 | $655.8K | 10b5-1 | Mar 3, 2026 | — | Form 144 ↗ |
| Mar 3, 2026 | Joseph Baroldi Officer | IONS Ionis Pharmaceuticals, Inc. | 4,096 | $325.1K | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 6,659 shares | Form 144 ↗ |
| Mar 3, 2026 | Joseph Klein III Director | IONS Ionis Pharmaceuticals, Inc. | 65,345 | $5.0M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 21,332 shares | Form 144 ↗ |
| Mar 3, 2026 | Shannon L. Devers Officer | IONS Ionis Pharmaceuticals, Inc. | 39,014 | $3.1M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 20,106 shares | Form 144 ↗ |
| Feb 13, 2026 | Eric Swayze Officer | IONS Ionis Pharmaceuticals, Inc. | 15,642 | $1.3M | 10b5-1 | Feb 13, 2026 | Form 4 ↗ same day · 15,642 shares | Form 144 ↗ |
| Feb 11, 2026 | Parshall B Lynne Director | IONS Ionis Pharmaceuticals, Inc. | 10,000 | $827.4K | 10b5-1 | Feb 11, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Feb 6, 2026 | Brett P. Monia Officer | IONS Ionis Pharmaceuticals, Inc. | 290,203 | $24.8M | 10b5-1 | Feb 6, 2026 | Form 4 ↗ 4 days later · 29,430 shares | Form 144 ↗ |
| Feb 2, 2026 | C. Frank Bennett Officer | IONS Ionis Pharmaceuticals, Inc. | 85,089 | $7.1M | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 2 days later · 85,089 shares | Form 144 ↗ |
| Jan 30, 2026 | Joseph Baroldi Officer | IONS Ionis Pharmaceuticals, Inc. | 5,296 | $439.7K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 5,296 shares | Form 144 ↗ |
| Jan 30, 2026 | Brian Birchler Officer | IONS Ionis Pharmaceuticals, Inc. | 6,179 | $512.3K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 6,179 shares | Form 144 ↗ |
| Jan 30, 2026 | C. Frank Bennett Officer | IONS Ionis Pharmaceuticals, Inc. | 5,885 | $487.9K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 5,885 shares | Form 144 ↗ |
| Jan 30, 2026 | Elizabeth L. Hougen Officer | IONS Ionis Pharmaceuticals, Inc. | 6,988 | $580.0K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 6,988 shares | Form 144 ↗ |
| Jan 30, 2026 | Brett P. Monia Officer, Director | IONS Ionis Pharmaceuticals, Inc. | 62,970 | $5.2M | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 62,970 shares | Form 144 ↗ |
| Jan 30, 2026 | Patrick R. O'Neil Officer | IONS Ionis Pharmaceuticals, Inc. | 6,179 | $512.9K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 6,179 shares | Form 144 ↗ |
| Jan 30, 2026 | Eric Swayze Officer | IONS Ionis Pharmaceuticals, Inc. | 6,179 | $512.9K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 6,179 shares | Form 144 ↗ |
| Jan 30, 2026 | Eugene Schneider Officer | IONS Ionis Pharmaceuticals, Inc. | 6,179 | $512.9K | — | Jan 30, 2026 | Form 4 ↗ 3 days later · 6,179 shares | Form 144 ↗ |
| Jan 23, 2026 amended | Shannon L. Devers Officer | IONS Ionis Pharmaceuticals, Inc. | 3,977 | $323.5K | 10b5-1 | Jan 22, 2026 | Form 4 ↗ 41 days later · 20,106 shares | Form 144/A ↗ |
| Jan 22, 2026 | Shannon L. Devers Officer | IONS Ionis Pharmaceuticals, Inc. | 3,977 | $323.5K | 10b5-1 | Jan 22, 2026 | Form 4 ↗ 1 day later · 3,977 shares | Form 144 ↗ |
| Jan 21, 2026 | Baroldi Mariana Member of immediate family of any of th… | IONS Ionis Pharmaceuticals, Inc. | 1,171 | $93.7K | — | Jan 16, 2026 | — | Form 144 ↗ |
| Jan 16, 2026 | Eric Swayze Officer | IONS Ionis Pharmaceuticals, Inc. | 9,884 | $753.5K | — | Jan 16, 2026 | Form 4 ↗ 4 days later · 9,933 shares | Form 144 ↗ |
| Jan 16, 2026 | Joseph Baroldi Officer | IONS Ionis Pharmaceuticals, Inc. | 6,999 | $559.9K | — | Jan 16, 2026 | Form 4 ↗ 4 days later · 8,056 shares | Form 144 ↗ |
| Jan 16, 2026 | C. Frank Bennett Officer | IONS Ionis Pharmaceuticals, Inc. | 8,977 | $684.3K | — | Jan 16, 2026 | Form 4 ↗ 4 days later · 8,977 shares | Form 144 ↗ |
| Jan 16, 2026 | Brian Birchler Officer | IONS Ionis Pharmaceuticals, Inc. | 8,480 | $646.4K | — | Jan 16, 2026 | Form 4 ↗ 4 days later · 8,480 shares | Form 144 ↗ |
| Jan 16, 2026 | Elizabeth L. Hougen Officer | IONS Ionis Pharmaceuticals, Inc. | 12,922 | $985.1K | — | Jan 16, 2026 | Form 4 ↗ 4 days later · 12,922 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances